Advancing Regulatory Systems for Improved Access to Safe, Effective, Affordable, and Quality-Assured Medical Products
Publish : 10th Jan 2023Many low- and middle-income countries (LMICs) have national regulatory authorities (NRAs) that are responsible for ensuring the safety, efficacy, affordability, and quality of medical products, including […]
Read More
Protocol for Active Safety Monitoring of a Dolutegravir-Based Antiretroviral Regimen in Mozambique
Publish : 10th Dec 2021Introduction Dolutegravir-based antiretroviral therapy (ART) is increasingly being used as the preferred first-line regimen for the treatment of HIV in low-income and middle-income countries. The National […]
Read More